WHO Expert Committee on Biological Standardization : thirty-seventh report, meeting held in Geneva from 1 to 8 December 1986
Material type:
TextSeries: World Health Organization technical report series ; no. 760Publication details: Geneva : World Health Organization, 1987Description: 203 Pages; 20 cmISBN: - 9241207604
- 100 SD;610.621 WHO.TR.760
| Item type | Current library | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|
| Reports | ISI Library, Kolkata Reports & Records Collection | 100 SD;610.621 WHO.TR.760 (Browse shelf(Opens below)) | Available | C21664 |
Browsing ISI Library, Kolkata shelves, Shelving location: Reports & Records Collection Close shelf browser (Hides shelf browser)
|
|
|
|
|
|
|
||
| 100 SD:610.621 WHO.TR.745 WHO Expert Committee on Biological Standardization (Thirty-sixth Report)/ | 100 SD:610.621 WHO.TR.746 Community-based education of health personnel: report of a who study group/ | 100 SD:610.621 WHO.TR.76 Expert Committee on Drugs Liable to Produce Addiction : fourth report | 100 SD;610.621 WHO.TR.760 WHO Expert Committee on Biological Standardization : thirty-seventh report, meeting held in Geneva from 1 to 8 December 1986 | 100 SD:610.621 WHO.TR.762 Training and education in occupational health : report of a WHO study group, meeting held in Geneva from 24 to 28 November 1986/ | 100 SD:610.621 WHO.TR.764 Rheumatic fever and rheumatic heart disease : Report of a Study Group, meeting held in Geneva, 30 March - 4 April 1987 | 100 SD:610.621 WHO.TR.765 Health promotion for working populations : report of a WHO expert committee, meeting held in Geneva from 9 to 15 June 1987/ |
General -- Substances: Antibiotics -- Antibodies -- Blood products and related substances -- Endocrinological and related substances -- Miscellaneous -- requirements for biological substances -- Annaxes
Announces changes in the status or development of international standards for 35 biologicals, classified as antibiotics, antibodies, antigens, blood products and related substances, endocrinological and related substances, and a miscellaneous group of substances. The report also provides detailed information on requirements for the manufacturing, testing, and quality control of selected vaccines, including hepatitis B vaccines made by recombinant DNA techniques in yeast, live mumps vaccine, and inactivated rabies vaccine produced in continuous cell lines. Of particular practical interest is an extensive report on a WHO meeting concerned with the use of recombinant DNA techniques to produce hepatitis B vaccines. The report also includes amendments to previous requirements for oral poliomyelitis vaccine and for diphtheria toxoid, pertussis vaccine, tetanus toxoid, and combined vaccines.
There are no comments on this title.
